0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Special Feature |

Picture of the Month—Diagnosis FREE

[+] Author Affiliations

Section Editor: Samir S. Shah, MD

More Author Information
Arch Pediatr Adolesc Med. 2008;162(11):1092. doi:10.1001/archpedi.162.11.1092.
Text Size: A A A
Published online

DENOUEMENT AND DISCUSSION: OSTEOMA CUTIS ASSOCIATED WITH PSEUDOHYPOPARATHYROIDISM TYPE 1A

The radiograph of the lower extremity lesion (Figure 2) showed microcalcifications limited to the subcutaneous region. The biopsy specimen (Figure 3) revealed mature lamellar bone limited to the epidermis and dermis, diagnosed as osteoma cutis. In light of these findings, as well as physical features of round facies and poor growth, a diagnosis of pseudohypoparathyroidism type 1a (PHP1a) was considered. Results of laboratory examination to explore potential associated endocrine abnormalities revealed an elevated thyrotropin (TSH) level of 8.82 mIU/L (reference range, 0.27-4.2 mIU/L), a normal free thyroxine level of 1.520 ng/dL (reference range, 1.01-1.79 ng/dL) (to convert to picomoles per liter, multiply by 12.871), and normal calcium, phosphorous, and parathyroid hormone levels. The child started thyroid hormone therapy.

Place holder to copy figure label and caption
Figure 2.

A radiograph of the left ankle demonstrates subcutaneous, radio-opaque lesions (arrows).

Graphic Jump Location
Place holder to copy figure label and caption
Figure 3.

A photomicrograph demonstrates mature lamellar bone (arrows) in the epidermis and dermis (hematoxylin-eosin).

Graphic Jump Location

Osteoma cutis, or ectopic extraskeletal ossification, is a rare disorder that typically presents in childhood with erythematous, hard subcutaneous nodules. Unlike many of the benign, nonspecific exanthems of childhood, osteoma cutis is a finding that heralds disorders with significant morbidity. These disorders can be divided into PHP1a or progressive osseous heteroplasia (POH), both associated with mutations of the alpha subunit of the adenylate cyclase stimulatory G protein (GNAS1)or fibrodysplasia ossificans progressiva, the latter associated with malformation of the great toes and mutations in the ACVR1gene.15In our patient, the absence of ectopic calcification of deep tissues (muscle and deep connective tissue) and the finding of short stature and elevated TSH level were strongly suggestive of the diagnosis of PHP1a, although recent reports suggest that POH-like ossification (associated with progressive, restricting ossification of deep tissues similar to fibrodysplasia ossificans progressiva) may occur in patients with clinical PHP, making a definitive diagnosis more difficult.611

Pseudohypoparathyroidism was first described by Fuller Albright, MD, in 1942. Classic findings include short stature, round facies, brachydactyly, soft tissue ossifications, and neurobehavioral and developmental problems, a phenotype known as Albright hereditary osteodystrophy. The disorder is inherited in an autosomal dominant manner with variable penetrance and tissue-specific resistance secondary to paternally determined imprinting of the GNASgene. Classically, maternal inheritance/imprinting results in PHP and paternal inheritance/imprinting results in pseudopseudohypoparathyroidism (clinical features without endocrine abnormalities) or pure POH. The mechanism of how GNASmutations lead to altered mesenchymal differentiation and resultant ectopic ossification is not understood.

With this in mind, the parents consented to have GNAS1mutation analysis performed on their son, with results revealing a Tyr37X alteration in exon 1, a termination mutation resulting in truncation of the GNAS protein. This result, with the physical examination findings and laboratory findings consistent with thyroid hormone resistance (elevated TSH level with normal free thyroxine level), confirmed the suspected diagnosis of PHP1a. Parents were provided genetic counseling for a 50% risk of future offspring carrying the same disorder and maternal mutation analysis was sent. The patient is being followed up for growth, neurodevelopment, and risk of associated endocrine abnormalities.

Osteoma cutis is a rare disorder that has mainly been reported in the orthopedic and dermatologic literature. However, it is important that pediatricians recognize this condition with the understanding that the initially mild cutaneous manifestations may herald a more progressive ossification disorder and/or be associated with multiple endocrine hormone resistance and neurobehavioral and developmental problems.

Return to .

Correspondence:Andrew Bauer, MD, Department of Pediatrics, Walter Reed Army Medical Center, 6900 Georgia Ave, Washington, DC 20307 (abauer@usuhs.mil).

Accepted for Publication:April 30, 2008.

Author Contributions:Study concept and design: Darling and Bauer. Acquisition of data: Darling and Bauer. Analysis and interpretation of data: Darling and Bauer. Drafting of the manuscript: Darling and Bauer. Critical revision of the manuscript for important intellectual content: Darling and Bauer. Administrative, technical, and material support: Darling and Bauer. Study supervision: Bauer.

Financial Disclosure:None reported.

Disclaimer:The opinions or assertions contained in this article are the private views of the authors and are not to be construed as reflecting the views of the US Army, Air Force, or the Department of Defense.

Davies  SJHughes  HE Imprinting in Albright's hereditary osteodystrophy. J Med Genet 1993;30 (2) 101- 103
PubMed Link to Article
Ahrens  WHiort  OStaedt  P  et al.  Analysis of the GNAS1 gene in Albright's hereditary osteodystrophy. J Clin Endocrinol Metab 2001;86 (10) 4630- 4634
PubMed
Shore  EMAhn  JDe Beur  SJ  et al.  Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia [published correction appears in N Engl J Med. 2002;346(21):1678]. N Engl J Med 2002;346 (2) 99- 106
PubMed Link to Article
Shore  EMXu  MFeldman  GJ  et al.  A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva [published correction appears in Nat Genet. 2007;39(2):276]. Nat Genet 2006;38 (5) 525- 527
PubMed Link to Article
Shore  EMFeldman  GJXu  MKaplan  FS The genetics of fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab 2005;3 (3-4) 201- 204
Link to Article
Goeteyn  VDe Potter  CRNaeyaert  JM Osteoma cutis in pseudohypoparathyroidism. Dermatology 1999;198 (2) 209- 211
PubMed Link to Article
Kaplan  FSGlaser  DLHebela  NShore  EM Heterotopic ossification. J Am Acad Orthop Surg 2004;12 (2) 116- 125
PubMed
Kaplan  FSShore  EM Progressive osseous heteroplasia. J Bone Miner Res 2000;15 (11) 2084- 2094
PubMed Link to Article
Gelfand  IMHub  RSShore  EMKaplan  FSDimeglio  LA Progressive osseous heteroplasia-like heterotopic ossification in a male infant with pseudohypoparathyroidism type Ia: a case report. Bone 2007;40 (5) 1425- 1428
PubMed Link to Article
Kaplan  FSCraver  RMacEwen  GD  et al.  Progressive osseous heteroplasia: a distinct developmental disorder of heterotopic ossification. Two new case reports and follow up of three previously reported cases. J Bone Joint Surg Am 1994;76 (3) 425- 436
PubMed
Kaplan  FSTabas  JAGannon  FH  et al.  The histopathology of fibrodysplasia ossificans progressiva: an endochondral process. J Bone Joint Surg Am 1993;75 (2) 220- 230
PubMed

Figures

Place holder to copy figure label and caption
Figure 2.

A radiograph of the left ankle demonstrates subcutaneous, radio-opaque lesions (arrows).

Graphic Jump Location
Place holder to copy figure label and caption
Figure 3.

A photomicrograph demonstrates mature lamellar bone (arrows) in the epidermis and dermis (hematoxylin-eosin).

Graphic Jump Location

Tables

References

Davies  SJHughes  HE Imprinting in Albright's hereditary osteodystrophy. J Med Genet 1993;30 (2) 101- 103
PubMed Link to Article
Ahrens  WHiort  OStaedt  P  et al.  Analysis of the GNAS1 gene in Albright's hereditary osteodystrophy. J Clin Endocrinol Metab 2001;86 (10) 4630- 4634
PubMed
Shore  EMAhn  JDe Beur  SJ  et al.  Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia [published correction appears in N Engl J Med. 2002;346(21):1678]. N Engl J Med 2002;346 (2) 99- 106
PubMed Link to Article
Shore  EMXu  MFeldman  GJ  et al.  A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva [published correction appears in Nat Genet. 2007;39(2):276]. Nat Genet 2006;38 (5) 525- 527
PubMed Link to Article
Shore  EMFeldman  GJXu  MKaplan  FS The genetics of fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab 2005;3 (3-4) 201- 204
Link to Article
Goeteyn  VDe Potter  CRNaeyaert  JM Osteoma cutis in pseudohypoparathyroidism. Dermatology 1999;198 (2) 209- 211
PubMed Link to Article
Kaplan  FSGlaser  DLHebela  NShore  EM Heterotopic ossification. J Am Acad Orthop Surg 2004;12 (2) 116- 125
PubMed
Kaplan  FSShore  EM Progressive osseous heteroplasia. J Bone Miner Res 2000;15 (11) 2084- 2094
PubMed Link to Article
Gelfand  IMHub  RSShore  EMKaplan  FSDimeglio  LA Progressive osseous heteroplasia-like heterotopic ossification in a male infant with pseudohypoparathyroidism type Ia: a case report. Bone 2007;40 (5) 1425- 1428
PubMed Link to Article
Kaplan  FSCraver  RMacEwen  GD  et al.  Progressive osseous heteroplasia: a distinct developmental disorder of heterotopic ossification. Two new case reports and follow up of three previously reported cases. J Bone Joint Surg Am 1994;76 (3) 425- 436
PubMed
Kaplan  FSTabas  JAGannon  FH  et al.  The histopathology of fibrodysplasia ossificans progressiva: an endochondral process. J Bone Joint Surg Am 1993;75 (2) 220- 230
PubMed

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles